Abraham George P, Siddaiah Avinash T, Das Krishanu, Ramaswami Krishnamohan, George Datson P, Thampan Oppukeril S
Department of Urology, Lakeshore and PVS Memorial Hospital, Kochi, Kerala, India.
J Minim Access Surg. 2015 Jul-Sep;11(3):187-92. doi: 10.4103/0972-9941.140217.
Pure laparoscopic nephrectomy in patients with ADPKD (autosomal dominant polycystic kidney disease) and ESRD (end-stage renal disease) on MHD (maintenance hemodialysis) is challenging with high incidence of complications. Limited experiences from India has been reported in these scenarios.
To present a 10-year single surgeon experience from India in laparoscopic nephrectomy in autosomal dominant polycystic kidneys (ADPKD) and end-stage renal disease (ESRD) on maintenance hemodialysis (MHD).
Retrospective.
Retrospective analysis of records of similar subset of patients who were offered laparoscopic nephrectomy between 2003 and 2012. Preoperative, operative and postoperative parameters were recorded. Few technical modifications were adopted over the years. Patients were sub-classified into two groups (Group I: 2003-2006, Group II: 2007-2012) based on surgical technique.
SAS software 9.1 version.
75 patients (84 renal units, Group I: 31, Group II: 53) were included in this analysis. Unilateral procedure was performed in 66 and bilateral staged or simultaneous procedure in 9. Despite larger kidneys in Group II (mean longitudinal renal length 25.7 ± 3.4 vs 17.5 ± 2.7 centimeters, P <0.001), improved operative and postoperative profile were noted in Group II in several parameters-mean total operative time (205 ± 11.5 vs 310 ± 15.3 min, P = 0.00), time for specimen retrieval (30.5 ± 3.5 vs 45 ± 4.1 min, P = 0.02), postprocedure drop in hemoglobin (1.1 ± 0.1 vs 2.27 ± 0.03 grams/deciliter, P = 0.00). Conversion rates, intraoperative and postoperative events were also considerably less in Group II.
Despite existence of comorbidities and technical difficulties, laparoscopic nephrectomy in patients with ADPKD with ESRD and on MHD is a feasible option. Technical modifications with increasing surgeon's experience allows successful conductance of this approach in more complex cases with better outcome.
对于接受维持性血液透析(MHD)的常染色体显性多囊肾病(ADPKD)和终末期肾病(ESRD)患者,实施单纯腹腔镜肾切除术具有挑战性,并发症发生率很高。在这些情况下,印度仅有有限的经验报道。
介绍一位印度外科医生在10年间对接受维持性血液透析(MHD)的常染色体显性多囊肾(ADPKD)和终末期肾病(ESRD)患者实施腹腔镜肾切除术的经验。
回顾性研究。
对2003年至2012年间接受腹腔镜肾切除术的类似患者亚组记录进行回顾性分析。记录术前、术中和术后参数。多年来采用了一些技术改进。根据手术技术将患者分为两组(第一组:2003 - 2006年,第二组:2007 - 2012年)。
SAS软件9.1版。
本分析纳入了75例患者(84个肾单位,第一组:31例,第二组:53例)。66例患者接受了单侧手术,9例患者接受了双侧分期或同期手术。尽管第二组患者的肾脏更大(平均肾脏纵径25.7±3.4厘米对17.5±2.7厘米,P<0.001),但在几个参数方面,第二组患者的手术及术后情况有所改善——平均总手术时间(205±11.5分钟对310±15.3分钟,P = 0.00)、取出标本时间(30.5±3.5分钟对45±4.1分钟,P = 0.02)、术后血红蛋白下降幅度(1.1±0.1克/分升对2.27±0.03克/分升,P = 0.00)。第二组的中转率、术中和术后事件也明显较少。
尽管存在合并症和技术困难,但对于接受MHD的ADPKD合并ESRD患者,腹腔镜肾切除术是一种可行的选择。随着外科医生经验的增加,技术改进使得这种方法能够在更复杂的病例中成功实施,并取得更好的结果。